Retinal Detachment after Open Globe Injury

Purpose To characterize the development of retinal detachment (RD) after open globe trauma. Design Case-control study. Participants A total of 892 patients comprising 893 open globe injuries (OGIs), of whom 255 were ultimately diagnosed with RD, with the remaining eyes serving as controls. Methods R...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ophthalmology (Rochester, Minn.) Minn.), 2014-01, Vol.121 (1), p.327-333
Hauptverfasser: Stryjewski, Tomasz P., MD, MPP, Andreoli, Christopher M., MD, Eliott, Dean, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose To characterize the development of retinal detachment (RD) after open globe trauma. Design Case-control study. Participants A total of 892 patients comprising 893 open globe injuries (OGIs), of whom 255 were ultimately diagnosed with RD, with the remaining eyes serving as controls. Methods Retrospective chart review of patients with OGIs presenting to the Massachusetts Eye and Ear Infirmary between 1999 and 2011. Kaplan–Meier analysis was used to estimate the time to detachment, and multivariable logistic regression was used to define the clinical factors associated with RD after OGI. Main Outcome Measures Demographic and clinical characteristics at the time of presentation after OGI, date of RD diagnosis, and last date of follow-up. Results Primary repair of the open globe was typically undertaken within hours of presentation. A total of 255 eyes were ultimately diagnosed with RD after open globe trauma, yielding an incidence of 29% (95% confidence interval, 26–32). For eyes that developed RD, 27% (69/255) detached within 24 hours of primary open globe repair, 47% (119/255) detached within 1 week, and 72% (183/255) detached within 1 month. Multivariable regression analysis revealed the presence of vitreous hemorrhage (odds ratio [OR], 7.29; P  
ISSN:0161-6420
1549-4713
DOI:10.1016/j.ophtha.2013.06.045